Načítá se...
Corneal Penetration of Topical and Subconjunctival Bevacizumab
PURPOSE. To investigate the ability of bevacizumab to penetrate the cornea after topical application or subconjunctival injection. METHODS. Bevacizumab 1% was topically applied three times a day to the corneas of mice (BALB/c) with intact corneas (n = 14), and with corneal neovascularization (n = 14...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Association for Research in Vision and Ophthalmology, Inc.
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3230312/ https://ncbi.nlm.nih.gov/pubmed/22003112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.11-7871 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|